Latest News

Q1 2024 Watch: Pandemic Medicaid protections ended; millions lost coverage; ADAP and veterans updates.

Q3 2023 Watch: HIV disparities coverage; debt ceiling crisis impacts; Medicaid disenrollment trends tracked.

Q2 2023 Watch: Braidwood decision impacts PrEP coverage; ADAP coverage analysis and Medicaid program updates.

Q1 2023 Watch: Tennessee rejecting federal HIV funding; updates on ADAPs, Medicaid, veterans care, and harm reduction.

Q4 2022 Watch: HHS renewed opioid emergency; CANN launched monkeypox project; HEPLISAV-B hepatitis B vaccine covered.

Federal executive actions protect LGBTQ people as states restrict gender-affirming care and trans rights.

Biden's SOTU addresses harm reduction, endorses MAT Act; limited HIV-specific programming focus.

NIH issues RFAs for Harm Reduction Network; Biden agenda targets decriminalization and safe consumption.

Analyzes CMS marketplace rule changes and Medicaid expansion risks as pandemic emergency declarations end.

Analyzes Biden health policy priorities including drug pricing reform and Medicare expansion.

Stagnant CMS reimbursement rates since 2016 threaten addiction treatment provider closures and service access.

Calls for restoring Obama-era guidance defining 340B patient protections and enforcement mechanisms.

Reviews Biden's first 100 days on healthcare: infrastructure, subsidies, harm reduction, and health equity.

Narrowly divided Senate limits Biden's health policy agenda, making regulatory actions the primary reform path.

CANN outlines advocacy priorities for the Biden era, from 340B reform and drug pricing to HIV criminalization and health equity.